Acquisitions10 Apr 2025, 02:06 am
Suraksha Diagnostic Completes Acquisition of Fetomat Wellness, Holding 63% Stake
AI Summary
Suraksha Diagnostic Limited has completed a strategic investment in Fetomat Wellness Private Limited, acquiring an amount not exceeding 35.19 crores in cash. This investment results in Suraksha Diagnostic holding a 63% equity stake in Fetomat, making Fetomat a subsidiary of the company. The acquisition was initially announced in March 2025, and the details were disclosed in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- Suraksha Diagnostic has completed the acquisition of Fetomat Wellness for up to 35.19 crores in cash.
- The company now holds a 63% equity stake in Fetomat, making Fetomat a subsidiary of Suraksha Diagnostic.
- The acquisition was initially announced in March 2025 and has now been completed.
- The acquisition details were disclosed in accordance with SEBI regulations.
- Fetomat is now a subsidiary of Suraksha Diagnostic Limited.